GP Promotional Pack. Sunderland Community Non-complicated Cellulitis Pathway. (Eron s Class II) Revised Version following RPIW JUNE 2015
|
|
- Myron Bell
- 5 years ago
- Views:
Transcription
1 GP Promotional Pack Sunderland Community Non-complicated Cellulitis Pathway (Eron s Class II) Revised Version following RPIW JUNE 2015 Version 3- Revised pathway following RPIW June 2015
2 Contents Section Description Page Number 1 Project Background 2 2 Service Outline Service Description and Pathway Diagnosis of Cellulitis Treatment 6 6 Management of healthcare associated infections 7 7 Project Evaluation 7 Appendix 1 Eron s Classification 8 Appendix 2 Telephone Referral Information 9 Appendix 3 Drug Therapy Record 10 Appendix 4 Cellulitis and Intravenous Antibiotics: Having your Treatment at Home 11 This document was originally produced by NHS SoT&W PCT QIPP Reform Team with the support of Sunderland CCG/CDU, PCT Medicines Management Team, City Hospitals Sunderland Microbiologists, A&E Colleagues and STFT Community Health Services with input from stakeholders within the project group. A further review took place in July with the amended paper re-released in November Contacts If you have any queries or require any information relating to this project please don t hesitate to contact: Name Designation Contact Details Iain Gilmour Sunderland CCG (0191) iain.gilmour@gp-a89001.nhs.uk David Robinson Sunderland CCG (0191) david.robinson@sotw.nhs.uk 1 - -
3 1.Project Background Cellulitis is a common painful skin infection, usually bacterial. Patients suffering from cellulitis can be treated with oral antibiotics, although many patients suffering from cellulitis require administration of intravenous (IV) drugs and a hospital admission. The infection most commonly affects the skin of the lower leg but can infect skin in any part of the body, usually following an injury to the skin. Cellulitis can affect people of all ages, including children; rates are thought to be roughly similar in both sexes. Known risk factors for cellulitis include: Having a weakened immune system Lymphoedema Intravenous drug misuse (injecting drugs such as heroin) HES data shows nationally approximately 56,000 of emergency admissions are for cellulitis, with patients having an average length of stay of 3 days. 1 In England, the number of annual cases of cellulitis has increased three-fold over the past 15 years. A Kaizen Event with GP s from the Wearside PBC Cluster in October 2010 identified a need for a standard referral form for GP s when requesting admission of patients into City Hospitals Sunderland (CHS). To underpin the work an audit was carried out at CHS to review emergency admissions for the quarter January to March The audit assessed the clinical aspect of why patients were admitted, a conclusion from the audit found that approximately 31% of admissions could have had an alternative management plan in the community. Majority of those patients were admitted for treatment for cellulitis, DVT or chest problems. Historically, in Sunderland, patients attending their GP with cellulitis are admitted to secondary care for IV antibiotic treatment. Some patients presenting at A&E with cellulitis are given their first dose of IV treatment at hospital and are discharged to the care of the Recovery at Home/Intermediate Care Community Nursing Team for completion of their treatment in their own home. The development of a primary care cellulitis pathway for Sunderland avoided the need for A&E attendances or hospital admissions for a clearly defined group of patients. Other areas of the country have adopted the same approach to manage cellulitis in primary care 2 ; all approaches have been considered in determining the most suitable robust pathway for the Sunderland area. 2. Service Outline This service will target all patients registered with a Sunderland GP who meet the referral criteria for treatment of non complicated cellulitis accordingly to Eron s Class II in the community. The decision to treat the patient in the community will be made by the referring clinician either GP, GP Out of Hours, GP led WiC or ED. A team of appropriately skilled community based nurses from Community Health Services (Recovery at Home Team) will administer IV medication in patient s homes to prevent admission to hospital. The service will be available 24 hours a day, 7 days a week. The service aims to: 1 HES Data: 2 Heywood, Middleton and Rochdale PCT Solihull PCT Brighton and Hove PCT
4 Reduce emergency admissions Reduce the risk of healthcare associated infections Increase the level of care being delivered in the patient s homes Increase patient independence Increase partnership with patients (through them having involvement in care planning, e.g. timing of administration) Deliver cost savings, by preventing admissions to secondary care 3. Service Description The Recovery at Home Team will provide a community based service to a clearly defined group of patients who are suffering from Eron s Class II cellulitis, in their own homes. If the patient meets the referral criteria for this service, they are referred to the Recovery at Home Team by the appropriate clinician using the identified referral documentation. Referrals to the Recovery at Home Team should be made by phone to the Recovery at Home Hub, and backed up by the relevant referral documentation, which is to be faxed to the Recovery at Home. The team will accept referrals for adults over the age of 18, the Recovery at Home team will carry out a routine risk assessment and the referring GP should alert the team of any known risk factors upon referral. The Recovery at Home Hub will take all relevant patient information during the initial telephone referral that is required for the Recovery at Home team to visit (Appendix 2). If routine bloods, swabs or investigations are required the Recovery at Home Team will carry out at time of cannulation, which are dependent upon the drug treatment. The GP will flag any anomalies with the blood or swab results for necessary action/treatment to be taken by the Recovery at Home team. During OOH periods (Friday Sunday) the Recovery at Home team will check patient blood results and liaise with the GP OOH service as necessary to ensure seamless care 24 hours a day, 7 days a week. The GP Receptionist will fax the drug treatment card to the Recovery at Home Team, then give the treatment card to the patient to take home to share with the Recovery at Home Team when they visit. The Receptionist will make the 48hour review appointment, document this on the patient leaflet and give this to the patient (Appendix 4). If this falls on a weekend the appointment will be made with the Recovery at Home GP. Patients should be given their i nformation leaflet and drug treatment card identifying the relevant drug prescribed for the patient; they can then share this with the Recovery at Home Team when they visit. If the referral is received from secondary care the Recovery at Home Team will visit to administer treatment. The ED/UCC or Recovery at Home Team will contact the surgery to arrange the review appointment for 48hours after commencement of treatment. The Recovery at Home Team will contact the patient within four hours of receipt of referral to confirm with the patient a suitable timescale for first contact and treatment to commence. IV drugs will be prescribed by the referring clinician and administered under an agreed drug protocol. IV Drugs will be supplied by the Recovery at Home service
5 While the patient is undergoing IV therapy they will remain the clinical responsibility of the referring clinician, but the drugs will be administered by the Recovery at Home Team. The drug protocols will clearly specify the responsibilities towards the patient, of each stakeholder in the service. During treatment the patient will be regularly monitored by the Recovery at Home Team. The team will liaise with the referring clinician, highlighting if the patient is not responding to treatment; or if the patient has responded and needs to be transferred to oral antibiotics. The decision to move from IV to oral antibiotics will be made by the patient s referring clinician in liaison with the Recovery at Home Team. Please see the detailed pathway described in Figure 1 overleaf
6 Figure One A&E Prescribe drugs on hospital drug chart IV cannula administer first dose Discharge patient to care of RAH Team Discharge include drugs/drug chart Appointment review at GP Practice Information leaflet including time of Nurse to visit GP/GP Led WiC s/oohs Diagnose cellulitis Eron s Class II Identify suitability for community IV antibiotics (inclusion/exclusion criteria) Discuss community pathway with patient Telephone RAH Team with relevant patient information Complete Drug Treatment Record Give patient information leaflet Telephone RAH Team Co-ordinator:? RAH Team co-ordinator ensures referral meets criteria for acceptance Yes No Arrange hospital Receptionist/GP fax Drug Treatment Record to RAH Team admission using Standard admission proforma RAH Team contact patient within 4 hours of receipt of referral to discuss time of visit. RAH Nurse will obtain IV antibiotics from stock. First Visit by RAH Team Discuss care to gain consent Cannulate and carry out routine investigations (blood/swabs) if necessary, dependent upon drug prescribed and bloods requested by GP Administer drugs Provide patient information leaflet with contact details Schedule next visit Responsive to treatment * - Referrer will review after 48 hours or if over a weekend RAH GP will review. RAH Team to discuss progress Ongoing review * Planned and unplanned according to patient s needs Deterioration * Discuss with referrer if appropriate or admit directly to hospital Discharge *GP in hours to notify abnormal blood results to Recovery at Home Team and plan alternative treatment if necessary. *Recovery at Home Team to check blood results and discuss with GP OOH between Friday Sunday periods. - -
7 4. Diagnosis of Cellulitis GP or medical practitioner will carry out clinical assessment; including risk factors and full patient history to establish diagnosis and Erons classification II cellulitis. Eron s classification system can be found in Appendix 1. Clinical features of cellulitis are 3 : Acute and progressive onset of red, painful, hot, swollen and tender skin with possible blister or bullae formation, usually unilateral Fever, malaise, shivering and rigors may precede or accompany the skin changes Spreading lymphangitis in severe cases Cause usually identifiable (such as laceration, burn, bite, leg ulceration, eczema). Differential diagnosis are identified in table one. Table One Common Varicose eczema DVT Acute gout Rare Gangrene Carcinoma Erisipeloides Necrotising fasciitis Acute lipopsclerosis Vasculitis Pyoderma gangrenosum Typical Cellulitis Bilateral Varicose Eczema Patient assessment to include the following, erythematous edges should be marked with indelible ink pen to allow subsequent clinical assessment of progress by the Recovery at Home Intermediate Care Team.: Temperature Blood pressure Heart Rate Respiration Rate Oxygen Saturation on air Patient weight if available Investigations to include the following, initial investigations will be carried out by the Recovery at Home Intermediate Care Team at the patient s first home visit:
8 FBC/U&E/LFT/CRP/Glucose/INR (if applicable) and routine swab if skin is broken or blistering this is dependent upon patient needs and GP clinical judgement Patients suitable and unsuitable for the pathway are identified in table two. Table Two Suitable Adults with uncomplicated cellulitis (Eron s Class II) Any patient who, on assessment, can be safely treated at home Unsuitable IV drug users Facial/ periorbital cellulitis Pregnancy/breastfeeding Known or suspected colonisation/infection with MRSA Whether to prescribe oral or intravenous antibiotics will be a matter of clinical judgement. IV antibiotics should be considered for patients with: Marked cellulitis (more than mild localised but not extensive) Mild systemic features (e.g. Flu-like symptoms, malaise) but not unwell Stable co-morbidity such as peripheral vascular disease, chronic venous insufficiency or morbid obesity which may complicate or delay resolution of their infection Cellulitis not improved on oral therapy 5. Treatment Following diagnosis of Class II cellulitis according to Eron s classification, patients suitable for the pathway should be referred to the Recovery at Home Team for treatment in the community. The three options of recommended IV treatments depending upon patient risk are outlined in Table 3. Table 3 No allergies or other contraindications Allergic to cephalosporins or anaphylactic to penicillins No particular risk of C.difficile infection Ceftriaxone IV* 1-2g once daily Under 80kg 1g, over 80kg 2g per day Review the morning after the second dose or next working day to decide whether to orally switch or continue Oral switch after 48/72 hours to Flucloxacillin (Complete 7 day course) Clindamycin IV* 600mg 6 hourly Review with the 7 th or 8 th dose or the next working day to decide whether to orally switch or continue. CDI within past 12 months or living in nursing home or otherwise deemed at high risk by the prescriber Flucloxacillin IV* 1-2g 6 hourly Review with the 7 th or 8 th dose to decide whether to orally switch or continue Oral switch after 48/72 hours to Flucloxacillin (Complete 7 day course ) Not suitable for the pathway Oral switch to Clindamycin 300mg qds (Complete 5 day course) ** Doses may need to be modified in light of renal function, liver function or extremes of body weight 6 - -
9 Drug cards can be found as Appendix 3. Intravenous to oral switch; patients should be reviewed at 48 hours or the next working day if at a weekend and if possible switch to oral preparations, suggested criteria are: Pyrexia settling Erythema settling Falling inflammatory markers if available Any co-morbidities stabilized If the patient has not improved at the time of review hospital referral should be considered 6. Management of Healthcare Associated Infections The list below outlines advice for GP and Recovery at Home Team to minimise the risk of C.difficile in the community: Nurse and GP to liaise following patients first symptoms of diarrhoea Test for C difficile and treat according to local guidelines if positive Review all antibiotic treatment if applicable Review and stop gastric acid suppressant therapy if applicable Do not prescribe antimotility medication 7.Evaluation of Pathway The following monitoring arrangements will be put in place to ensure the pathway is operating as planned: Cellulitis activity data will be collected and monitored quarterly at the Project Group Meetings to inform the key metrics below: Number of referrals and from Sunderland GP s to CHS A&E Number of admissions from Sunderland GP s to CHS Number of referrals to Recovery at Home Team Number of inappropriate referrals to Recovery at Home Team ie. Class I,111 & IV Number of patients switched to oral medication within 72 hours Number of referrals from CHS A&E department to Recovery at Home Team Any evidence of patients on the pathway who have developed C difficile Number and range of antibiotics prescribed Identify the number of practices operating the pathway 7 - -
10 Appendix 1 Eron s Severity Classification System Eron LJ (2000) 4 devised this classification system of skin and soft tissue infections to aid the GP/Nurse diagnosis, treatment and admission decisions. Once a diagnosis of lower limb cellulitis has been made a decision should be made as to admission/treatment options according to the following classification system. Please see Figure 2: Class I Patients have no signs of systemic toxicity, have no uncontrolled co-morbidities and can usually be managed with oral antimicrobials. Class II Patients are either systemically ill or systemically well but with a co-morbidity such as peripheral vascular disease, chronic venous insufficiency or morbid obesity which may complicate or delay resolution of their infection. Class III Patients may have a significant systemic upset such as acute confusion, tachycardia, tachypnoea and hypotension or may have unstable co-morbidities that may interfere with a response to therapy or have a limb threatening infection due to vascular compromise. Class IV Patients have sepsis syndrome or severe life threatening infection such as necrotizing fasciitis. Clinical findings alone are usually adequate for diagnosing cellulitis, particularly in non-toxic immunocompetent patients. Figure 2 Treatment in the community Hospital admission Eron s Class I Oral Flucloxacillin Eron s Class II IV antibiotics Eron s Class III Eron s Class IV 4
11 Appendix 2 Telephone Referral Information Patient Demographics Name: Address: Telephone Number: D.O.B. GP Practice Details Name of Referrer: GP Practice: Telephone Number: Reason for Referral Erons classification BP Temp Heart Rate Respiratory Rate Oxygen Sats on air Past Medical History Allergies Routine Investigations required
12 Appendix 3 DRUG THERAPY RECORD - COMMUNITY NURSING RECORDS Patient s Name: Date of Birth: NHS Number: Address: G.P.: G.P Address: Patient stelephone No.: Home: Work: Mobile: Other cards in use: G.P. Telephone No.: Allergies: All drugs and changes of drug therapy to be recorded before administration by nursing staff Regular Prescriptions Date Drug Name, Strength and Preparation Dose Route Frequency Additional Instructions Ceftriaxone injection 1g Iv bolus Once daily Reconstitute the vial with 10ml water for injection according to the IV guide and administer as bolus over 2-4 minutes Ceftriaxone injection 2g Iv Once daily Reconstitute the vial with 40ml sodium chloride 0.9% and infusion infuse over 30 minutes Clindamycin injection 600mg Iv Every 6 hours Prepare the clinidamycin infusion according to the IV infusion guide and administer Infusion over minutes for each 600mg of clindamycin Flucloxacillin injection 1g Iv Every 6 hours Reconstitute the vial according to the IV guide and Sodium chloride 0.9% 5ml iv Before and After antibiotic administer as bolus over 2-4 minutes Flush the line with 5ml sodium chloride 0.9% before and after administration of antibiotic Prescriber s Name (PRINT) and Signature Date Discontinued
13 Appendix 4 Cellulitis and Intravenous Antibiotics: Having your Treatment at Home You have been given this leaflet because your doctor/practitioner has seen you and diagnosed cellulitis. The doctor/practitioner has prescribed intravenous antibiotic treatment for you to be given at home. The doctor has referred you to the Recovery at Home Team who will contact you at your home within 4 hours to arrange to visit. Their telephone number is fax number What is cellulitis? Cellulitis is an infection of the deep layer of skin [dermis] and the layer of fat and tissues just under the skin [the subcutaneous tissues]. It is generally caused by a break in the skin that has allowed bacteria [germs] to get into and under the skin. Various types of bacteria can cause cellulitis. What is the treatment for cellulitis? A course of antibiotic tablets will often clear cellulitis but sometimes, as in this case, more is needed and intravenous antibiotic treatment is needed. This is where the antibiotic is injected into a vein. You will be contacted by the Recovery at Home Team who will visit you at your home. They will bring the intravenous antibiotics with them to administer at each visit. The Recovery at Home Team will visit twice daily to monitor condition and administer your medications. Your doctor will review you after 48 hours of treatment. This has been arranged for you on at You should contact the Recovery at Home Team (or your doctor) sooner however if the area of infection continues to spread or you become worse after you start your antibiotic treatment. The nurse from the Recovery at Home Team will provide you with a full information leaflet so that you can monitor your symptoms and treatment but things you need to know about now are: some patients may develop diarrhoea; this can occur up to 2-3 weeks after finishing treatment, you should tell the Recovery at Home Team nurse or contact your doctor if you develop diarrhoea elevating (raising) the affected body part uses gravity to help prevent excess swelling, which may also ease pain painkillers such as paracetamol or ibuprofen can ease pain and reduce fever and make you feel generally more comfortable using a moisturiser cream and soap substitute on the affected area of skin until it heals to help prevent the skin from becoming dry and damaged drinking plenty of fluids helps prevent dehydration and can make you feel generally more comfortable you may need a tetanus booster vaccination / human tetanus immunoglobulin if you have had dirty cut or wound and your tetanus injections are not up-to-date You should contact your nurse or doctor for advice immediately if you notice any of these symptoms. Pain 'out of proportion' to the look of the skin changes Feeling unwell and becoming ill 'out of proportion' to the look of the skin Symptoms that get worse rapidly - either skin symptoms, or how you feel generally Affected skin that goes dusky, purple or blistering 10
Unless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version
Policy No: MM09 Version: 1.0 Name of Policy: Gateshead Cellulitis Pathway 2017: Primary, Community and Acute Care Effective From: 27/06/2017 Date Ratified 14/06/2017 Ratified Medicines Governance Group
More informationManagement of Adults with Lower Limb Cellulitis
Management of Adults with Lower Limb Cellulitis Community IV Therapy Team Guideline (Brighton and Hove area) Parent Policy / Policies Intravenous therapy administration for adults and children Medicines
More informationOPAT CELLULITIS PATHWAY
OPAT CELLULITIS PATHWAY ANY exclusion criteria for OPAT Sepsis syndrome Active drug/alcohol abuse Active underlying orthopaedic condition Craniofacial cellulitis Failure to improve with > 48hrs IV Rx YES
More informationIV Antibiotics for Patients with Cellulitis
Policy Number LCH-93 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational
More informationCommunity Intravenous Therapy Referral Standards
pecialist harmacy ervice Medicines Use and afety Community Intravenous Therapy Referral tandards Background A multi-centred audit of prescribing and administration of community IV therapy across East and
More informationHealth & Social Services
The States of Jersey Department for Health & Social Services AGREED PROCESS FOR COMMUNITY INTRAVENOUS THERAPY Date approved DOCUMENT PROFILE Document Registration Document Purpose Short Title Author Publication
More informationCyclophosphamide INFUSION Infusion 4 Plus
Cyclophosphamide Infusion Day DEPARTMENT OF RHEUMATOLOGY DAY CASE ADMISSION RECORD PATIENT DAY CASE BOOKING REQUEST To be completed by Consultant, Registrar requesting day case Admission Hospital No. Forename
More informationStoryboard submission
Storyboard submission Follow the detailed instructions in this template for writing a description of your storyboard. Type your information in each section below and save this completed storyboard document
More informationWound Care and. February Lymphoedema Service
Wound Care and February 2016 Lymphoedema Service Contents Introduction... 2 About the service... 2 Service provision... 2 Advice, education and training... 4 Service locations and hours of operation...
More informationPatient Self Administration of Intravenous (IV) Antibiotics at Home
Trust Policy Document Ref. No: PP(16)319 Patient Self Administration of Intravenous (IV) Antibiotics at Home For use in: For use by: For use for: Document owner: Status: Clinical Areas Clinical Staff Patient
More informationYour varicose vein operation
Day Surgery Centre Your varicose vein operation patientinformation Rotherham Hospital Your health, your choice, our passion Your varicose vein operation This booklet gives a guide to your day case varicose
More informationInguinal hernia repair integrated care pathway (ICP)
Name Ward Hosp no DOB Affix patient label Inguinal hernia repair integrated care pathway (ICP) Inclusion criteria Patients undergoing inguinal hernia repair aged under 3 months corrected gestational age
More informationSetting up and running a community IV therapy clinic
Setting up and running a community IV therapy clinic Moving care to the community has been a UK-wide health and social care priority for more than a decade (Royal College of Nursing [RCN], 2013). With
More informationPROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS
STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients
More informationMETICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change
METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 10/2008 1 Guidance
More informationBlood clot prevention. A guide for patients and carers
Blood clot prevention A guide for patients and carers Contents Introduction 1 What is a venous thromboembolism (VTE)? 1 What is a deep vein thrombosis (also known as a DVT)? 1 What is a pulmonary embolism
More informationCLINICAL PROTOCOL National Early Warning Score (NEWS) Observation Chart
CLINICAL PROTOCOL National Early Warning Score (NEWS) Observation Chart November 2014 1 Document Profile Type i.e. Strategy, Policy, Procedure, Guideline, Protocol Title Category i.e. organisational, clinical,
More information*Your Name *Nursing Facility. radiation therapy. SECTION 2: Acute Change in Condition and Factors that Contributed to the Transfer
Gaining information about resident transfers is an important goal of the OPTIMISTC project. CMS also requires us to report these data. This form is where data relating to long stay transfers are to be
More informationAbout your peritoneal dialysis catheter. Information for patients Sheffield Kidney Institute (Renal Unit)
About your peritoneal dialysis catheter Information for patients Sheffield Kidney Institute (Renal Unit) Introduction You will have discussed with your doctor that your kidney condition means that you
More informationAdministration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure
Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Quality and Standards Group Date
More informationDISTRICT NURSING and INTERMEDIATE CARE
CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above
More informationModified Early Warning Score Policy.
Trust Policy and Procedure Modified Early Warning Score Policy. Document ref. no: PP(15)271 For use in (clinical areas): For use by (staff groups): For use for (patients): Document owner: Status: All clinical
More informationHickman line insertion and caring for your line
Hickman line insertion and caring for your line Information for patients This booklet explains how a Hickman line is put in, the benefits, the risks and the alternatives, as well as how to care for your
More informationGENERAL CONSENT TO TREAT
GENERAL CONSENT TO TREAT DATE: PATIENTS NAME: DATE OF BIRTH: MRN: Consent: I request and authorize medical or surgical treatment as may be deemed necessary and appropriate by the physician and his/her
More informationDirectorate Medical Operations Patients and Information Nursing Policy Commissioning Development
Review of National Reporting and Learning System (NRLS) incident data relating to discharge from acute and mental health trusts August 2014 NHS England INFORMATION READER BOX Directorate Medical Operations
More informationNon-cancer related bilateral mastectomy pre-operative information sheet
Non-cancer related bilateral mastectomy pre-operative information sheet This leaflet explains more about non-cancer related bilateral mastectomy surgery, including the benefits, risks and any alternatives
More informationAre you at risk of blood clots?
Are you at risk of blood clots? DVT (deep vein thrombosis) & PE (pulmonary embolism) Information for patients in hospital or going home from hospital Are you at risk of blood clots? (DVT & PE) This leaflet
More informationMeatoplasty/canalplasty
Meatoplasty/canalplasty What is a meatoplasty/canalplasty and why do I need this operation? This operation is performed to widen your ear canals so that they do not get blocked with wax and debris. It
More informationThe operation will take several hours and you will stay in the recovery room until you are ready to return to the ward.
This booklet is designed to give you information about having a free flap following a lower limb injury. We hope it will answer some of the questions that you, or those who care for you, may have at this
More informationHaving a portacath insertion in the x-ray department
Having a portacath insertion in the x-ray department This leaflet provides information about a portacath insertion, including the benefits, risks and any alternatives. It also explains what you can expect
More informationSepsis guidance implementation advice for adults
Sepsis guidance implementation advice for adults NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation
More informationDocument Author: Tissue Viability Nurse Date 15/02/2017
Guideline Title: Ref No: 1820 Version: 2 Document Author: Tissue Viability Nurse Date 15/02/2017 Ratified by: Care and Clinical Policies Group Date: 15/02/2017 Review date: 10 March 2019 Links to policies:
More informationOxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9
Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 3 January 2017 Paper No: 9 Title of Presentation: OCCG Primary Care Locally Commissioned Services
More informationINFORMATION FOR PATIENTS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E- mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk INFORMATION
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Managing neutropenic sepsis in secondary and tertiary care bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly
More informationLiver tumour ablation
Radiology Department Liver tumour ablation Information for patients What is Ablation? You have been selected by your doctor to have ablation treatment for your liver tumour. Ablation is a technique that
More informationExcision of Submandibular Gland
Patient information Excision of Submandibular Gland Ear, Nose and Throat Directorate PIF 863 V5 Your consultant has advised that you have excision of submandibular gland. What is excision of submandibular
More informationIMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE
Art & science The acute district synthesis care nursing of art and science is lived by the nurse in the nursing act JOSEPHINE G PATERSON IMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE
More informationPatient Information Varicose Vein Surgery Dr Marek Garbowski. Varicose Veins
Contents: Welcome Varicose veins Our expectations Preadmission clinic The day of your operation In preparation of going home Discharge advice following varicose veins surgery Contacts Varicose Veins Welcome
More informationProactive Care Team Contingency Plan Original completed: Patient Details. Frameworki Number: First Name: Margaret Lives Alone: Yes No
Proactive Care Team Contingency Plan Original completed: Patient Details Surname: Jones NHS Number: Frameworki Number: First Name: Margaret Lives Alone: Yes No Known As: Maggie Key safe: Yes No Number
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationMorton s neuroma. If you have any further questions, please speak to a doctor or nurse caring for you.
Morton s neuroma This leaflet aims to answer your questions about having surgery for Morton s neuroma. It explains the benefits, risks and alternatives, as well as what you can expect when you come to
More informationHOSPITAL IN THE HOME (HITH) INFORMATION SHEET
What is HITH? HOSPITAL IN THE HOME (HITH) INFORMATION SHEET In 1994 the Hospital in the Home (HITH) Program was commenced as a pilot. Hospitals were invited to apply to become HITH providers and 43 were
More informationPatient information. Breast Reconstruction TRAM Breast Services Directorate PIF 102 V5
Patient information Breast Reconstruction TRAM Breast Services Directorate PIF 102 V5 Your consultant has recommended that you have a TRAM flap to reconstruct your breast. TRAM stands for Transverse Rectus
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationSerious Incident Report Public Board Meeting 28 July 2016
Serious Incident Report Public Board Meeting 28 July 2016 Presented for: Presented by: Author Previous Committees Governance Dr Yvette Oade, Chief Medical Officer Louise Povey, Serious Incidents Investigations
More informationContents. Welcome to the Cath Lab P4/5
Contents Welcome to the Cath Lab Preparation Instructions : information to ensure you are ready for your procedure in the Cath Lab, set out for you as questions (Q) and answers (A) How the day will go
More informationWelcome to Sils Dialysis!
Welcome to Sils Dialysis! If you would like to have your dialysis treatment with us, please contact us directly at info@silsdialysis.com as soon as you have your dates. It is very important that you book
More informationAnaphylactic Reaction Emergency Treatment Reference Number:
This is an official Northern Trust policy and should not be edited in any way Anaphylactic Reaction Emergency Treatment Reference Number: NHSCT/12/551 Target audience: Nursing Staff Groups included are:
More informationThe School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT
The School Of Nursing And Midwifery. BMedSci Nursing (Adult) CLINICAL SKILLS PASSPORT Student Details NAME: COHORT: I understand that this booklet may be reviewed by my mentor, the programme leader, my
More informationDischarge Advice Following Breast Reconstructive Surgery
Oxford University Hospitals NHS Trust Discharge Advice Following Breast Reconstructive Surgery Information for patients This leaflet contains answers to some of the questions people most often ask when
More informationPROTOCOL FOR VENESECTION
PROTOCOL FOR VENESECTION Author: Scope: Date: Dr John de Vos All staff who carry out venesection June 2015 (original June 2006 Dr Janet Shirley) Ratified by: Clinical Audit and Effectiveness Committee
More informationSentinel node biopsy. Patient Information to be retained by patient
PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label Sentinel Node Biopsy What is a sentinel node biopsy? The lymphatic drainage from your
More informationSection 7: Core clinical headings
Section 7: Core clinical headings Core clinical heading standards: the core clinical headings are those that are the priority for inclusion in EHRs, as they are generally items that are the priority for
More informationSCHEDULE 2 THE SERVICES Service Specifications
SCHEDULE 2 THE SERVICES Service Specifications Service Specification No Service ParaDoc Commissioner City and Hackney CCG Commissioner Lead Leah Herridge Provider CHUHSE Provider Lead Date of Review September
More informationRegistered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework
Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Name: Location: Date commenced: Contents Competency: Page No: Page 1. Core: Introduction Demonstrate knowledge that
More informationPROCEDURE FOR THE ADMINISTRATION OF HOMELY REMEDIES IN COMMUNITY HOSPITALS
PROCEDURE FOR THE ADMINISTRATION OF HOMELY REMEDIES IN COMMUNITY HOSPITALS Document Details Title Procedure for the administration of Homely Remedies in Community Hospitals Trust Ref No 1896-36344 Local
More informationDepartment of Neurosurgery. Pre-operative Assessment Clinic Information for patients
Department of Neurosurgery Pre-operative Assessment Clinic Information for patients Before you come in for your operation you will be asked to come to the Pre-operative Assessment Clinic. These clinics
More informationC-GALL PATIENT INFORMATION LEAFLET
C-GALL PATIENT INFORMATION LEAFLET The purpose of this study is to compare keyhole gall bladder surgery (laparoscopic cholecystectomy) with watchful waiting in people who suffer from pain due to gallstones
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s
More informationTAKING VENOUS BLOOD SAMPLES FROM HEALTHY ADULT VOLUNTEERS
TAKING VENOUS BLOOD SAMPLES FROM HEALTHY ADULT VOLUNTEERS 1. SCOPE A number of studies performed in the University involve taking samples of venous blood from participants. A wide variety of tests may
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine-Doxorubicin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationTop copy accepted by patient: yes/no (please ring)
Consent Form 3 Patient / Parental agreement to investigation or treatment Procedures where consciousness not impaired Name of proposed procedure or course of treatment Hospital NHS Surname no: no: OUTPATIENT
More informationRecognising a Deteriorating Patient. Study guide
Recognising a Deteriorating Patient Study guide Recognising a deteriorating patient Recognising and responding to clinical deterioration Background Clinical deterioration can occur at any time in a patient
More informationTenckhoff Catheter Insertion
Tenckhoff Catheter Insertion Information for patients with chronic kidney disease (CKD) who have chosen to have peritoneal dialysis Renal Directorate Produced: May 2010 Review date: May 2012 This leaflet
More informationIndependent investigation into the death of Mr Cyril Beedle at Victoria House Approved Premises on 15 November 2015
Independent investigation into the death of Mr Cyril Beedle at Victoria House Approved Premises on 15 November 2015 Crown copyright 2015 This publication is licensed under the terms of the Open Government
More informationPHARMACIST AMENDMENT OF PRESCRIBING REGIMENS AND COMPILING LISTS OF TAKE HOME MEDICATION POLICY AND PROCEDURE
Wirral University Teaching Hospital NHS Foundation Trust Policy / Procedure Reference: 045j PHARMACIST AMENDMENT OF PRESCRIBING REGIMENS AND COMPILING LISTS OF TAKE HOME MEDICATION POLICY AND PROCEDURE
More informationFoot Ulcers. An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Foot Ulcers An information guide Foot Ulcers What is a foot ulcer? An ulcer is a medical term for an open sore. Foot ulcers are serious
More informationExtracorporeal Shock Wave Lithotripsy (ESWL) An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Extracorporeal Shock Wave Lithotripsy (ESWL) An information guide Extracorporeal Shock Wave Lithotripsy (ESWL) What does the procedure involve?
More informationPerioperative management of the higher risk surgical patient with an acute surgical abdomen undergoing emergency surgery
CLINICAL GUIDELINE Perioperative management of the higher risk surgical patient with an acute surgical abdomen undergoing emergency surgery CG10214-2 For use in (clinical areas): For use by (staff groups):
More informationLaparoscopic Radical Nephrectomy
Urology Department Laparoscopic Radical Nephrectomy Information Aims of this leaflet To give information on the intended benefits and potential risks of kidney surgery To guide you in the decisions you
More informationPATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix )
PATIENT GROUP DIRECTION Administration of: By: Practice Nurses Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix ) In: General Practice It is the responsibility of the professional working
More informationPATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title
Patient identifier/label: Page 1 of 5 GENERIC CONSENT FORM Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other identifier) Male Female Special requirements
More informationPressure Injuries. Care for Patients in All Settings
Pressure Injuries Care for Patients in All Settings Summary This quality standard focuses on care for people who have developed or are at risk of developing a pressure injury. The scope of the standard
More informationLinking the LAS with Health & Social Care. 6 th December 2016
Linking the LAS with Health & Social Care 6 th December 2016 Outline: About me.. LAS Context Integrating LAS with H&SC London Ambulance Service NHS Trust 2 LAS context London Ambulance Service NHS Trust
More informationEnhanced Recovery Programme for total hip and knee replacement Orthopaedic Department Patient Information Leaflet
Enhanced Recovery Programme for total hip and knee replacement Orthopaedic Department Patient Information Leaflet What is the Enhanced Recovery Programme? This leaflet aims to give you information on what
More informationPercutaneous Endoscopic Gastrostomy (PEG)
Patient information leaflet Royal Surrey County Hospital NHS Foundation Trust Percutaneous Endoscopic Gastrostomy (PEG) Nursing and Clinical Governance Why do I need a feeding tube? You may be due to have
More informationThis SLA covers an enhanced service for care homes for older people and not any other care category of home.
Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service
More informationCare of Your Peripherally Inserted Central Catheter
Care of Your Peripherally Inserted Central Catheter A guide for patients and their carers Acute Oncology Patient Information Leaflet Contents Information for patients: What is a PICC? How is it put in?
More informationSHOCKWAVE LITHOTRIPSY FOR STONES
Procedure Specific Information What is the evidence base for this information? This publication includes advice from consensus panels, the British Association of Urological Surgeons, the Department of
More informationStage 2 GP longitudinal placement learning outcomes
Faculty of Life Sciences and Medicine Department of Primary Care & Public Health Sciences Stage 2 GP longitudinal placement learning outcomes Description This block focuses on how people and their health
More informationAbbvie 3D for the treatment of Hepatitis C Genotype 1
Abbvie 3D for the treatment of Hepatitis C Genotype 1 Department of Hepatology Digestive Diseases Centre Patient Information This leaflet is designed to give you important information about your new medicine.
More informationCNA SEPSIS EDUCATION 2017
CNA SEPSIS EDUCATION 2017 WHAT CAUSES SEPSIS? Sepsis occurs when the body has a severe immune response to an infection Anyone who has an infection is at risk for developing sepsis Sepsis occurs when the
More informationYou and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath Nursing A guide for patients and carers Contents What is a TIVAD?... 1 Why is a TIVAD necessary?... 2 How a TIVAD is inserted...
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cetuximab (+/- platinum-based chemotherapy) HOSPITAL NAME/STAMP: PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH:
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationNHS HIGHLAND. Significant Event Report
` NHS HIGHLAND Significant Event Report Report to - Quality & Patient Safety Raigmore Management Team of Findings from Significant Event Review Meeting QPS040 26/10/2011 1.0 Outline of Significant Event
More informationHaving trabeculectomy surgery
Having trabeculectomy surgery This leaflet aims to answer some of the questions you may have about having trabeculectomy surgery. It explains the benefits, risks and alternatives of the procedure as well
More informationPatient Controlled Analgesia Guidelines
Patient Controlled Analgesia Guidelines Date: August 2005 Ref : PCD005 Vers : 2 Policy Profile Policy Reference Number PCD005 Version 2 Status Approved Trust Lead Director of Nursing/Acute Pain Team Implementation
More informationGuidance on the Enhanced Recovery Programme in Colorectal Surgery Surgery Patient Information Leaflet
Guidance on the Enhanced Recovery Programme in Colorectal Surgery Surgery Patient Information Leaflet Originator: Mr Raj Patel Date: May 2011 Version: 2 Date for Review: May 2014 DGOH Ref No: DGOH/PIL/00364
More informationHarvoni for the treatment of Hepatitis C
Harvoni for the treatment of Hepatitis C Department of Hepatology Digestive Diseases Centre Patient Information This leaflet is designed to give you important information about your new medicine. It is
More informationTotally Implantable Venous Access Devices (port) Information for patients. Cross section of a port
Cystic Fibrosis Unit, Ward 26 0121 424 2000 Information for Patients Totally Implantable Venous Access Devices (port) Information for patients This leaflet tells you about the procedures for Totally Implantable
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX) Patient s surname/family name Patient s first names Date of birth Hospital
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION
Patient identifier/label: Page 1 of 6 CYTARABINE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital
More informationInfliximab Infusion for Patients with Ulcerative Colitis Patient Information Leaflet
Infliximab Infusion for Patients with Ulcerative Colitis Patient Information Leaflet Originator: Lindsey Wood Date: March 2011 Version: 2 Date for Review: March 2014 DGOH Ref No: DGOH/PIL/00304 Contact
More informationAntimicrobial Stewardship in Continuing Care. Nursing Home Acquired Pneumonia Clinical Checklist
Antimicrobial Stewardship in Continuing Care Nursing Home Acquired Pneumonia Clinical Checklist March 2015 What is Antimicrobial Stewardship? Using the: right antimicrobial agent for a given diagnosis
More informationSupporting Self Care Choose Pharmacy Common Ailments Service GP Practice Guide
Supporting Self Care Choose Pharmacy Common Ailments Service GP Practice Guide Contents Section 1: Introduction Section 2: Service Information Section 3: Conditions to be Treated Section 4: Referrals &
More informationLondon s Urgent and Emergency Care Collaborative
London s Urgent and Emergency Care Collaborative Katy Millard London Community Services Director Claire Eves Operational Head of Hillingdon Health Care Partnership Thomas Dowle Clinical & Operational Lead,
More information